BPC-157 Results Timeline
What the standard BPC-157 research protocol looks like phase by phase, over a typical 8–16 weeks cycle. This is the escalation schedule from our full dosing protocol, presented as a timeline rather than a table.
Quick Facts
FREQUENCYOnce daily
CYCLE LENGTH8–16 weeks
DOSE RANGE200–600 mcg/day
ROUTESubcutaneous injection
Phase-by-Phase Timeline
Loading / Titration
Weeks 1–2
Target dose: 200 mcg (0.2 mg)
Escalation
Weeks 3–4
Target dose: 400 mcg (0.4 mg)
Maintenance
Weeks 5–8+
Target dose: 600 mcg (0.6 mg)
Reported in Research
- ✓Gradual titration from 200 mcg up to 600 mcg over the first 4 weeks.
- ✓Run for 8–12 weeks continuously.
- ✓Extend to 16 weeks if desired.
- ✓Follow with a 2–4 week break before repeating.
This timeline reflects the structure of the standard BPC-157 research protocol documented on this site — it is not a guarantee of individual outcomes, and timelines vary between research subjects. All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.